Synthesis and Biological Evaluation of Quinolinone Compounds as SARS CoV 3CL<sup>pro</sup>Inhibitors
作者:Yuanpei Sun、Ning Zhang、Jian Wang、Yu Guo、Bo Sun、Wei Liu、Honggang Zhou、Cheng Yang
DOI:10.1002/cjoc.201300392
日期:2013.7.19
SARSCoV 3CLpro is known to be a promising target for development of therapeutic agents against the severe acute respiratory syndrome (SARS). A quinolinonecompound 1 was selected via virtual screening, and it was synthetized and tested for enzymatic inhibition in vitro. Compound 1 showed potent inhibitory activity (IC50=0.44 µmol/L) toward SARSCoV 3CLpro. Further work on a series of quinolinone derivatives